REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 77 filers reported holding REPARE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,135,655 | +14.2% | 3,322,488 | 0.0% | 0.85% | +33.9% |
| Q2 2023 | $35,151,923 | +7.5% | 3,322,488 | 0.0% | 0.64% | -0.8% |
| Q1 2023 | $32,693,282 | -33.1% | 3,322,488 | 0.0% | 0.64% | -31.3% |
| Q4 2022 | $48,873,798 | +21.3% | 3,322,488 | 0.0% | 0.94% | +25.0% |
| Q3 2022 | $40,302,000 | -13.3% | 3,322,488 | 0.0% | 0.75% | -11.2% |
| Q2 2022 | $46,482,000 | -1.8% | 3,322,488 | 0.0% | 0.84% | +9.8% |
| Q1 2022 | $47,312,000 | -32.5% | 3,322,488 | 0.0% | 0.77% | -14.9% |
| Q4 2021 | $70,071,000 | -19.6% | 3,322,488 | 0.0% | 0.90% | -5.9% |
| Q3 2021 | $87,182,000 | -18.4% | 3,322,488 | -3.0% | 0.96% | -11.4% |
| Q2 2021 | $106,833,000 | +1.6% | 3,426,325 | 0.0% | 1.08% | +10.0% |
| Q1 2021 | $105,154,000 | -10.5% | 3,426,325 | 0.0% | 0.98% | -4.4% |
| Q4 2020 | $117,523,000 | +11.5% | 3,426,325 | 0.0% | 1.03% | -22.4% |
| Q3 2020 | $105,428,000 | -0.8% | 3,426,325 | 0.0% | 1.32% | -11.4% |
| Q2 2020 | $106,285,000 | – | 3,426,325 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |